L Tabár1, P B Dean. 1. University of Uppsala Faculty of Medicine, Department of Mammography, Falun Central Hospital, Falun, Sweden. laszlo@mammographic.org
Abstract
OBJECTIVES: To review the evidence demonstrating that early detection of breast cancer substantially decreases death from the disease, and to demonstrate that the significant change in the outcome of breast cancer patients results from a combination of early detection and surgical removal of breast cancer, as treatment of the late stage disease provides little impact on ultimate outcome. METHOD: Review results of the randomized controlled trials of mammographic screening and the published results of service screening. RESULTS: Both randomized controlled trials and service screening, when performed properly, provide unequivocal evidence demonstrating that arresting the disease in its preclinically detectable phase has significant impact on outcome. Primary emphasis should be upon preventing breast cancer from developing to metastatic disease. CONCLUSIONS: Numerous scientific trials have repeatedly and convincingly confirmed that breast cancer is progressive rather than a systemic disease from its inception. Progression of breast cancer can be arrested through detection and treatment at an early phase. The time at which disease progression is arrested has significant impact on clinical outcome, making mammographic screening a key factor in the control of breast cancer.
OBJECTIVES: To review the evidence demonstrating that early detection of breast cancer substantially decreases death from the disease, and to demonstrate that the significant change in the outcome of breast cancerpatients results from a combination of early detection and surgical removal of breast cancer, as treatment of the late stage disease provides little impact on ultimate outcome. METHOD: Review results of the randomized controlled trials of mammographic screening and the published results of service screening. RESULTS: Both randomized controlled trials and service screening, when performed properly, provide unequivocal evidence demonstrating that arresting the disease in its preclinically detectable phase has significant impact on outcome. Primary emphasis should be upon preventing breast cancer from developing to metastatic disease. CONCLUSIONS: Numerous scientific trials have repeatedly and convincingly confirmed that breast cancer is progressive rather than a systemic disease from its inception. Progression of breast cancer can be arrested through detection and treatment at an early phase. The time at which disease progression is arrested has significant impact on clinical outcome, making mammographic screening a key factor in the control of breast cancer.
Authors: Flemming Forsberg; Babita Kuruvilla; Mark B Pascua; Manisha H Chaudhari; Daniel A Merton; Juan P Palazzo; Barry B Goldberg Journal: Ultrasound Med Biol Date: 2008-04-24 Impact factor: 2.998
Authors: Sanaz A Jansen; Xiaobing Fan; Gregory S Karczmar; Hiroyuki Abe; Robert A Schmidt; Gillian M Newstead Journal: Magn Reson Med Date: 2008-04 Impact factor: 4.668
Authors: Ami Vyas; Suresh Madhavan; Traci LeMasters; Elvonna Atkins; Sara Gainor; Stephenie Kennedy; Kimberly Kelly; Linda Vona-Davis; Scot Remick Journal: J Community Health Date: 2012-06
Authors: Whitney Levano; Jacqueline W Miller; Banning Leonard; Linda Bellick; Barbara E Crane; Stephenie K Kennedy; Natalie M Haslage; Whitney Hammond; Felicia S Tharpe Journal: Cancer Date: 2014-08-15 Impact factor: 6.860